🇺🇸 OZAGREL in United States

98 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Cerebral Infarction — 32 reports (32.65%)
  2. Depressed Level Of Consciousness — 8 reports (8.16%)
  3. Hepatic Function Abnormal — 8 reports (8.16%)
  4. Pneumonia Aspiration — 8 reports (8.16%)
  5. Renal Impairment — 8 reports (8.16%)
  6. Haemorrhagic Cerebral Infarction — 7 reports (7.14%)
  7. Interstitial Lung Disease — 7 reports (7.14%)
  8. Muscle Haemorrhage — 7 reports (7.14%)
  9. Platelet Count Decreased — 7 reports (7.14%)
  10. Alanine Aminotransferase Increased — 6 reports (6.12%)

Source database →

OZAGREL in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is OZAGREL approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for OZAGREL in United States?

Marketing authorisation holder not available in our data.